热门资讯> 正文
InMed收到纳斯达克关于股权要求的通知
2026-09-19 05:47
- InMed Pharmaceuticals (INM) said on Friday it received a Nasdaq notice after reporting shareholders' equity of $1.08M, below the $2.5M minimum required for continued listing.
- The company has 45 days to submit a compliance plan. It expects its planned merger with Mentari Therapeutics and related financing to restore compliance.
More on InMed Pharmaceuticals
- Historical earnings data for InMed Pharmaceuticals
- Financial information for InMed Pharmaceuticals
风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。